Mark pursued his bachelor’s degree in health sciences at McMaster university. Driven to address the health inequalities he saw in his communities growing up, Mark pursued his medical degree at the University of Ottawa. He hasa special interest in rural, Indigenous, and addictions medicine. He has travelled to remote northern First Nations reserves for the past seven years, living on reserve for weeks while leading support programs. Combining this work with his passion for research, he haspublishednumerous papers and presented at conferences onHIV care, patient engagement, and First Nations health. His research interests include HIV health and thyroid nodule ablation,
Mark pursued his bachelor’s degree in health sciences at McMaster university. Driven to address the health inequalities he saw in his communities growing up, Mark pursued his medical degree at the University of Ottawa. He hasa special interest in rural, Indigenous, and addictions medicine. He has travelled to remote northern First Nations reserves for the past seven years, living on reserve for weeks while leading support programs. Combining this work with his passion for research, he haspublishednumerous papers and presented at conferences onHIV care, patient engagement, and First Nations health. His research interests include HIV health and thyroid nodule ablation, as well as patient engagement and First Nations health.
Dr. Samir Al-Adawi is a professor of Behavioral Medicine at College of Medicine, Sultan Qaboos University. Previously, he was a Fulbright Senior Scholar at the Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, USA and a research scientist sponsored by Matsumae International Foundation at the Department of Psychosomatic Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. His doctorate training was at the Institute of Psychiatry, Kings College, UK. Dr. Al-Adawi has research interests that focus on non-communicable diseases. His research and publications have specifically focused on psychosocial determinants of health and ill-health since biological sciences
Dr. Samir Al-Adawi is a professor of Behavioral Medicine at College of Medicine, Sultan Qaboos University. Previously, he was a Fulbright Senior Scholar at the Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, USA and a research scientist sponsored by Matsumae International Foundation at the Department of Psychosomatic Medicine, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan. His doctorate training was at the Institute of Psychiatry, Kings College, UK. Dr. Al-Adawi has research interests that focus on non-communicable diseases. His research and publications have specifically focused on psychosocial determinants of health and ill-health since biological sciences alone in the prevention of and intervention in matters related to diseases appear to be an unattainable aspiration in the emerging economies such as Oman. Dr. Al-Adawi is a member of the World Health Organization Expert Consultation Group on Feeding and Eating Disorders, reporting to the International Advisory Group for the Revision of International Classification of Diseases (ICD-10 Mental and Behavioural Disorders.
I am a professor of the department of life science at Northwest University, China. I am interested in know how the pathogens cause disease and are resistant to antibiotics. Presently, Combing the high through-put sequencing (ChIP-seq and RNA-seq) with biochemical methods, we are investigating the molecular mechanisms of several regulators of quorum-sensing in Pseudomonas aeruginosa and how this bacterial cause hosts disease.
I am a professor of the department of life science at Northwest University, China. I am interested in know how the pathogens cause disease and are resistant to antibiotics. Presently, Combing the high through-put sequencing (ChIP-seq and RNA-seq) with biochemical methods, we are investigating the molecular mechanisms of several regulators of quorum-sensing in Pseudomonas aeruginosa and how this bacterial cause hosts disease.
Maurizio Pompili is currently Professor of Suicidology and Associate Professor of Psychiatry as part of the Faculty of Medicine and Psychology of Sapienza University of Rome, Italy, where he received his M.D. degree, where he trained in Psychiatry and where he has doctoral degree in Experimental and Clinical Neurosciences. He is the Director of the Suicide Prevention Center at Sant Andrea Hospital in Rome. He was also part of the Community at McLean Hospital Harvard Medical School, USA where he received a fellowship in psychiatry. He is the recipient of the American Association of Suicidology 2008 Shneidman Award for Outstanding
Maurizio Pompili is currently Professor of Suicidology and Associate Professor of Psychiatry as part of the Faculty of Medicine and Psychology of Sapienza University of Rome, Italy, where he received his M.D. degree, where he trained in Psychiatry and where he has doctoral degree in Experimental and Clinical Neurosciences. He is the Director of the Suicide Prevention Center at Sant Andrea Hospital in Rome. He was also part of the Community at McLean Hospital Harvard Medical School, USA where he received a fellowship in psychiatry. He is the recipient of the American Association of Suicidology 2008 Shneidman Award for Outstanding contributions in research in suicidology. He is part of IASP Task Force for Emergency Medicine and Suicidal Behavior and the International Research Group on Suicide in Older Adults. He is currently the Italian representative for International Association for Suicide Preventionas well as the Co-Chair of the IASP Council of National Representatives. He is also member of the International Academy for Suicide Research and the American Association of Suicidology. Professor Pompili has provided validation studies of the Beck Hopelessness Scale, Reason for Living Inventory, TEMPS-A for the Italian population researching the interplay of factors that may precipitate suicide both in clinical and non-clinical samples. He has published more than 300 papers. Maurizio is particularly active in collaborations the Italian Ministry of Health and Italian Health Institute. H-index: 26 (Scopus, May 2014).
Chadi is Medical Advisor of Global Patient Safety, GPS Medical and Benefit-Risk Management. He is Center Medical Director and Center Laboratory Director of Grifols Plasma Operations. Chadi is an Staff Physician of Jasper Memorial Hospital at present. He is an Adjunct Professor for Phase IV Drug Development of Butler University, Indianapolis. He has completed his Fellowship in Nephrology from Staten Island University Hospital in 2013 and Master of Public Health from Benedictine University in 2010.
Chadi is Medical Advisor of Global Patient Safety, GPS Medical and Benefit-Risk Management. He is Center Medical Director and Center Laboratory Director of Grifols Plasma Operations. Chadi is an Staff Physician of Jasper Memorial Hospital at present. He is an Adjunct Professor for Phase IV Drug Development of Butler University, Indianapolis. He has completed his Fellowship in Nephrology from Staten Island University Hospital in 2013 and Master of Public Health from Benedictine University in 2010.
Tomohiko Shimatani was born in 1965 in Tokyo, Japan. He received his Ph.D. in 1998 and M.D. in 1990 from Hiroshima University. A Ph.D. thesis was 'Pharmacological regulation of interdigestive and postprandial gastrointestinal motility by glucagon in conscious dogs'. He completed his residency in internal medicine in Hiroshima University Hospital, Hiroshima Red Cross Hospital and National Otake Hospital. He is triple board certified in Internal Medicine, Gastroenterology and Gastroenterological Endoscopy. Since 2007, he is a professor of faculty of nursing, Hiroshima International University in Kure, Japan. Current responsibilities include clinical commitments in gastroenterology and general internal medicine. Teaching commitments include
Tomohiko Shimatani was born in 1965 in Tokyo, Japan. He received his Ph.D. in 1998 and M.D. in 1990 from Hiroshima University. A Ph.D. thesis was 'Pharmacological regulation of interdigestive and postprandial gastrointestinal motility by glucagon in conscious dogs'. He completed his residency in internal medicine in Hiroshima University Hospital, Hiroshima Red Cross Hospital and National Otake Hospital. He is triple board certified in Internal Medicine, Gastroenterology and Gastroenterological Endoscopy. Since 2007, he is a professor of faculty of nursing, Hiroshima International University in Kure, Japan. Current responsibilities include clinical commitments in gastroenterology and general internal medicine. Teaching commitments include lectures and seminars on gastroenterology and internal medicine to undergraduate medical and nursing students and postgraduates. Principal research interests have focused on the study of acid-related diseases (in particular, gastroesophageal reflux disease) and Helicobacter pylori infection. Recently, more basic work is commenced on pharmacokinetics/dynamics of proton pump inhibitors. Current responsibilities include clinical commitments in gastroenterology and general internal medicine. Teaching commitments include lectures and seminars on gastroenterology and general internal medicine to undergraduate medical and nursing students and postgraduates. Principal research interests focus on the study of epidemiology, pathophysiology and pharmacotherapy of acid-related diseases (including gastroesophageal reflux disease) and Helicobacter pylori infection. Recently, more basic work is commenced on pharmacokinetics/dynamics of proton pump inhibitors.
HUI Rutai Professor of Medicine and professor of Genetic and Genomic Medicine. Medicine at Shandong University medical school & Peking Union Medical College, China; PhD at University of Montreal, Canada, Post-doctor at NIH, USA. Presently as a cardiologist at Beijing Fuwai Hospital; as a principal investigator at National Heart Center of China. Main research interests are genetic and epigenetics relevant to cardiovascular disease and hypertension. A cohort of 10,000 hypertensive patients from 20 communities has been following up to explore environmental factors, genetic and epigenetic factors which may contribute to hypertension, resistant hypertension, stroke and myocardial infarction. Genomic DNA of
HUI Rutai Professor of Medicine and professor of Genetic and Genomic Medicine. Medicine at Shandong University medical school & Peking Union Medical College, China; PhD at University of Montreal, Canada, Post-doctor at NIH, USA. Presently as a cardiologist at Beijing Fuwai Hospital; as a principal investigator at National Heart Center of China. Main research interests are genetic and epigenetics relevant to cardiovascular disease and hypertension. A cohort of 10,000 hypertensive patients from 20 communities has been following up to explore environmental factors, genetic and epigenetic factors which may contribute to hypertension, resistant hypertension, stroke and myocardial infarction. Genomic DNA of the patients with hypertrophic cardiomyopathy was employed to identify HCM-causing genes and genetic modifiers by using second-generation sequencing tool. Having 149 publications, as correspondence author, published in more than 20 peer reviewed journals, including Circulation, Circulation Research, JACC, Hypertension, Stroke, Atherosclerosis, Am J Hum Genet, Hum Mol Genet.
Professor of tropical infectious diseases, post-graduate course, Faculty of Veterinary Medicine, University of Teramo, Italy. Former professor of microbiology, Iwate University, Japan. With more than 20 years of experience in virology research at national and international levels, Prof Giangaspero work includes interest in emerging and potentially zoonotic diseases as investigations on bovine viral diarrhea virus (BVDv) in man or association of BVDv with HIV in human patients. Currently, Prof Giangaspero is developing virus genome secondary structure based identification methods applied to pestiviruses and human hepatitis C virus species. Prof Giangaspero institutional activities included strengthening of sanitary veterinary institutions in the
Professor of tropical infectious diseases, post-graduate course, Faculty of Veterinary Medicine, University of Teramo, Italy. Former professor of microbiology, Iwate University, Japan. With more than 20 years of experience in virology research at national and international levels, Prof Giangaspero work includes interest in emerging and potentially zoonotic diseases as investigations on bovine viral diarrhea virus (BVDv) in man or association of BVDv with HIV in human patients. Currently, Prof Giangaspero is developing virus genome secondary structure based identification methods applied to pestiviruses and human hepatitis C virus species. Prof Giangaspero institutional activities included strengthening of sanitary veterinary institutions in the framework of EU assistance as Pre-Accession Adviser in Slovenia or technical assistance to food safety and veterinary authorities in Albania, Bangladesh, Croatia Lithuania, Poland, Romania and Zambia.
Prakash C. Deedwania is one of the most recognizable figures in the fields of ischemic heart disease, hypertension, lipid disorders, rhythm disorders and preventive cardiology. He is Professor of Medicine at the University of California San Francisco (UCSF) School of Medicine and is Director of Heart Failure Program at Community Regional Medical Center /UCSF Program in Fresno. Dr. Deedwania is also Director of Cardiovascular Research for the UCSF Fresno-Central San Joaquin Valley Medical Education Program and Clinical Professor of Medicine at Stanford University in Palo Alto. Dr. Deedwania is a fellow of the American Heart association, American college of Cardiology,
Prakash C. Deedwania is one of the most recognizable figures in the fields of ischemic heart disease, hypertension, lipid disorders, rhythm disorders and preventive cardiology. He is Professor of Medicine at the University of California San Francisco (UCSF) School of Medicine and is Director of Heart Failure Program at Community Regional Medical Center /UCSF Program in Fresno. Dr. Deedwania is also Director of Cardiovascular Research for the UCSF Fresno-Central San Joaquin Valley Medical Education Program and Clinical Professor of Medicine at Stanford University in Palo Alto. Dr. Deedwania is a fellow of the American Heart association, American college of Cardiology, American College of Chest Physician, American College of Physician, American, and a member of the American Thoracic Society, the American Federation of Clinical Research, the Council on Silent Myocardial Ischemia and Infarction, the International Society of Ambulatory Science and the New York Trudeau Society. He has served as Chair of the Executive Committee of the Laennec Society of the American Heart Association and he is currently President of the California Chapter of the American Society of Hypertension. He recently served on the joint writing group of AHA/ADA/ACC for the position statement on intensive glucose control in patients with diabetes.
Dr. Amy is an international leader in preventing heart attacks, stroke and diabetes. She is the co-founders of the Bale/Doneen Method and the co-principle lecturer and researcher for this method of CVD Prevention. Her research on CVD prevention has been published in such respected medical journals as Atherosclerosis, Post Graduate Medicine, Journal of the National Medical Association, Journal of Clinical Lipidology, Cardiology Roundtable, Physicians Weekly, Cardiovascular Nursing, Dental Economics, Alternative Therapies in Health and Medicine and ADVANCE for Healthy Aging and others. Having given well over a thousand lectures to global medical groups, including to the International Atherosclerosis Society, International
Dr. Amy is an international leader in preventing heart attacks, stroke and diabetes. She is the co-founders of the Bale/Doneen Method and the co-principle lecturer and researcher for this method of CVD Prevention. Her research on CVD prevention has been published in such respected medical journals as Atherosclerosis, Post Graduate Medicine, Journal of the National Medical Association, Journal of Clinical Lipidology, Cardiology Roundtable, Physicians Weekly, Cardiovascular Nursing, Dental Economics, Alternative Therapies in Health and Medicine and ADVANCE for Healthy Aging and others. Having given well over a thousand lectures to global medical groups, including to the International Atherosclerosis Society, International Symposium on Atherosclerosis, Womens Heart Symposium, American Heart Association, Cleveland Heart Lab, National Dental and Family Practice Organizations, she is a sought-after thought leader in vascular wellness. Doneen has served as a reviewer for medical journals on topics revolving around vascular imaging and served on the appropriate use committee for the Society of Atherosclerotic Imaging and Prevention. Doneen is the medical director of Heart Attack & Stroke Prevention Center and adjunct Professor at Texas Tech Health Sciences School of Nursing. She is also the past chair of the Pacific Northwest Preventative Cardiovascular Nurses Association.
Dr. Guerin studied Psychology at DeSales University (BSc) and Temple University (PhD). She is a veteran of the US Navy where she was a nuclear valve technician on board the USS Samuel Gompers before commencing her academic career. From 1996-2005, Dr. Guerin was variously employed in New Zealand at the University of Waikato, the Ruakura Agricultural Research Centre, and the Waikato Institute of Technology. From late 2005, Dr. Guerin worked in Australia at the University of South Australia and then at Flinders University, mainly teaching Health Psychology and Indigenous Health. Since mid-2012, she has been the Psychology Program Coordinator at
Dr. Guerin studied Psychology at DeSales University (BSc) and Temple University (PhD). She is a veteran of the US Navy where she was a nuclear valve technician on board the USS Samuel Gompers before commencing her academic career. From 1996-2005, Dr. Guerin was variously employed in New Zealand at the University of Waikato, the Ruakura Agricultural Research Centre, and the Waikato Institute of Technology. From late 2005, Dr. Guerin worked in Australia at the University of South Australia and then at Flinders University, mainly teaching Health Psychology and Indigenous Health. Since mid-2012, she has been the Psychology Program Coordinator at the Pennsylvania State University Brandywine Campus. She is the co-author of the award winning Australian book, Healthcare and Indigenous Australians: Cultural Safety in Practice, as well as numerous research publications. She has presented her work nationally and internationally to a range of health and social service related professionals and academics. My relevant areas of expertise are in cultural safety (competence) of health care professionals, racism in healthcare, mental health and wellbeing, female circumcision, physical activity, smoking cessation.
Lavi Oud received an M.D. degree from the Technion School of Medicine, Israel. He has completed his post-graduate training in Internal Medicine at Morristown Memorial Hospital and clinical and research fellowships in Critical Care Medicine at Wayne State University. Dr. Oud is an Associate Professor of Medicine at Texas Tech University School of Medicine and the Chief of the Division of Pulmonary and Critical Care Medicine at the Texas Tech University Health Sciences Center at the Permian Basin. He is a Fellow of the American College of Chest Physicians, and the American College of Physicians. His clinical research focuses on
Lavi Oud received an M.D. degree from the Technion School of Medicine, Israel. He has completed his post-graduate training in Internal Medicine at Morristown Memorial Hospital and clinical and research fellowships in Critical Care Medicine at Wayne State University. Dr. Oud is an Associate Professor of Medicine at Texas Tech University School of Medicine and the Chief of the Division of Pulmonary and Critical Care Medicine at the Texas Tech University Health Sciences Center at the Permian Basin. He is a Fellow of the American College of Chest Physicians, and the American College of Physicians. His clinical research focuses on the metabolic response to injury, health care systems, and outcomes in critically ill patients.
Alexander V. Sergeev is a tenured faculty member at the Ohio University Department of Social and Public Health. He has an extensive professional experience in clinical medicine, health research, and public health. Prior to joining Ohio University. Dr. Sergeev was a medical school faculty member at Smolensk State Medical Academy (Russia) and practiced as a physician in a teaching hospital. Dr. Sergeev serves as the director of the Epidemiology in Public Health; Chronic Disease Epidemiology, Prevention, and Control; and Advanced Epidemiology courses at the Consortium of Eastern Ohio Master of Public Health Program (CEOMPH). He also worked at the New
Alexander V. Sergeev is a tenured faculty member at the Ohio University Department of Social and Public Health. He has an extensive professional experience in clinical medicine, health research, and public health. Prior to joining Ohio University. Dr. Sergeev was a medical school faculty member at Smolensk State Medical Academy (Russia) and practiced as a physician in a teaching hospital. Dr. Sergeev serves as the director of the Epidemiology in Public Health; Chronic Disease Epidemiology, Prevention, and Control; and Advanced Epidemiology courses at the Consortium of Eastern Ohio Master of Public Health Program (CEOMPH). He also worked at the New York State Department of Health and the Institute for Health and the Environment at the University at Albany-State University of New York (SUNY). Dr. Sergeevs research interests focus on cardiovascular disease epidemiology, chronic diseases epidemiology, health care utilization patterns, and quantitative methods in health research.
Dr. Xing-Ding Zhang received his Master and Ph.D. of Medicine degree in the Department of Pharmacology and the Laboratory of Aging and Nervous Diseases at Soochow University in Suzhou, China. Then, he performed a one-year post-doctoral fellowship in the Cyrus Tang Hematology Center at Soochow in Tumor Molecular Biology. Finally, he got three year postdoctoral fellowship training in the University of Texas MD Anderson Center, which is the best Cancer center in USA. Dr. Zhang published more than 10 in peer-review leading international journals and supported by 10 grants in China and USA. He also is serving as an editorial
Dr. Xing-Ding Zhang received his Master and Ph.D. of Medicine degree in the Department of Pharmacology and the Laboratory of Aging and Nervous Diseases at Soochow University in Suzhou, China. Then, he performed a one-year post-doctoral fellowship in the Cyrus Tang Hematology Center at Soochow in Tumor Molecular Biology. Finally, he got three year postdoctoral fellowship training in the University of Texas MD Anderson Center, which is the best Cancer center in USA. Dr. Zhang published more than 10 in peer-review leading international journals and supported by 10 grants in China and USA. He also is serving as an editorial board member and reviewer in more than 10 journals. Dr. Zhangs research focused on the ubiquitin-proteasome pathway as a target for multiple myeloma, and on mechanisms of resistance. He also interested in seeking to establish the mechanisms of Programmed cell death (Autophagy and Apoptosis) in Neurodegenerative diseases and multiple myeloma.
Dibyendu received his PhD in molecular biology and biophysics from the University of Calcutta, India in 2009. Currently, he is an associate faculty of Biochemistry at Albert Einstein College of Medicine, USA. Dibyendu worked on the structure-function relationship of T cell costimulatory molecules for long time. He has also engineered MHC molecules which has immense therapeutic potential against type-1 diabetes. Dibyendu published many papers in leading international journals. Presently, Dibyendu is interested in structure-guided protein engineering for the development of novel biologics against cancers and autoimmune diseases.
Dibyendu received his PhD in molecular biology and biophysics from the University of Calcutta, India in 2009. Currently, he is an associate faculty of Biochemistry at Albert Einstein College of Medicine, USA. Dibyendu worked on the structure-function relationship of T cell costimulatory molecules for long time. He has also engineered MHC molecules which has immense therapeutic potential against type-1 diabetes. Dibyendu published many papers in leading international journals. Presently, Dibyendu is interested in structure-guided protein engineering for the development of novel biologics against cancers and autoimmune diseases.
Dr. Yuka Kotozaki is an assistant professor, Division of Clinical Research, Medical-Industry Translational Research Center, Fukushima Medical University School of Medicine. She received her PhD from the Tohoku University. Her specialization is psychology (cognitive psychology and clinical psychology). After East Japan great earthquake disaster of the 2011, she continues a study of the mental health of the victim at the stricken area. Research interest are Women, Victims, Mental health, PTSD, Psychological support for victims, Psychotherapy, and Biomarkers.
Dr. Yuka Kotozaki is an assistant professor, Division of Clinical Research, Medical-Industry Translational Research Center, Fukushima Medical University School of Medicine. She received her PhD from the Tohoku University. Her specialization is psychology (cognitive psychology and clinical psychology). After East Japan great earthquake disaster of the 2011, she continues a study of the mental health of the victim at the stricken area. Research interest are Women, Victims, Mental health, PTSD, Psychological support for victims, Psychotherapy, and Biomarkers.
Daisuke Onozuka, Ph.D., is Assistant Professor of the Department of Health Care Administration and Management at the Kyushu University Graduate School of Medical Sciences. Dr. Onozuka received his Ph.D. (in Medical Sciences) from the Kyushu University Graduate School of Medical Sciences, Japan. He was previously in the Department of Public Health and Medical Affairs at Fukuoka Prefectural Government, and Fukuoka Institute of Health and Environmental Sciences. His areas of expertise pertain to infectious disease epidemiology and Yusho disease. My research interests cover most of environmental epidemiology. Current substantive research topics of interest, on which my work in collaboration with both
Daisuke Onozuka, Ph.D., is Assistant Professor of the Department of Health Care Administration and Management at the Kyushu University Graduate School of Medical Sciences. Dr. Onozuka received his Ph.D. (in Medical Sciences) from the Kyushu University Graduate School of Medical Sciences, Japan. He was previously in the Department of Public Health and Medical Affairs at Fukuoka Prefectural Government, and Fukuoka Institute of Health and Environmental Sciences. His areas of expertise pertain to infectious disease epidemiology and Yusho disease. My research interests cover most of environmental epidemiology. Current substantive research topics of interest, on which my work in collaboration with both international and Japanese colleagues, focus mainly on the impacts of weather and global climate change on health, but also include health risks of air pollution.
Dr. Keinan-Boker received both her MD degree (1984-1987) and her BSc (Basic Medical Sciences) degree from the Hebrew University of Jerusalem (1981-1987). In 1988 through 1990, Dr. Keinan-Boker practiced medicine as a general practitioner in the Police Headquarters in Jerusalem, Israel. Dr. Keinan-Boker completed her residency in Public Health in 1993-1997 in Israel. During this time she also obtained an MPH degree (cum laude) from the Hebrew University, Jerusalem, Israel. In 1999-2002 Dr. Keinan-Boker studied for a Ph.D. at the Utrecht University, in Utrecht, the Netherlands. In 2003 she had a position of a post-doc in the same institute. Since
Dr. Keinan-Boker received both her MD degree (1984-1987) and her BSc (Basic Medical Sciences) degree from the Hebrew University of Jerusalem (1981-1987). In 1988 through 1990, Dr. Keinan-Boker practiced medicine as a general practitioner in the Police Headquarters in Jerusalem, Israel. Dr. Keinan-Boker completed her residency in Public Health in 1993-1997 in Israel. During this time she also obtained an MPH degree (cum laude) from the Hebrew University, Jerusalem, Israel. In 1999-2002 Dr. Keinan-Boker studied for a Ph.D. at the Utrecht University, in Utrecht, the Netherlands. In 2003 she had a position of a post-doc in the same institute. Since 2003 Dr Keinan-Boker is the Deputy Director in the Israel Center for Disease Control (ICDC). Since 2005 Dr. Keinan-Boker is faculty in the School of Public Health of the University of Haifa as well. She is currently an assistant professor and her main research topics involve cancer epidemiology. My main interests are cancer epidemiology, cancer etiology, nutrition and cancer, cancer screening, early exposures that modify cancer risk.
Dr. Park is an Assistant Professor of Medicine at Harvard Medical School and research assistant at Boston Childrens Hospital. Dr. Parks research focuses on understanding the mechanism by which type 2 diabetes and insulin resistance develop in obesity. Dr. Park and her colleagues have identified X--]box binding protein--]1 (XBP1), a transcription factor, as a key regulator of ER stress and insulin resistance in obesity and reported a novel interaction of XBP1s with the regulatory subunits of phosphatidyl--]inositol3--]kinse (PI3K). Dr. Parks current research aims to investigate the role of bromodomain binding protein in ER stress, insulin resistance and obesity. Research Interests:
Dr. Park is an Assistant Professor of Medicine at Harvard Medical School and research assistant at Boston Childrens Hospital. Dr. Parks research focuses on understanding the mechanism by which type 2 diabetes and insulin resistance develop in obesity. Dr. Park and her colleagues have identified X--]box binding protein--]1 (XBP1), a transcription factor, as a key regulator of ER stress and insulin resistance in obesity and reported a novel interaction of XBP1s with the regulatory subunits of phosphatidyl--]inositol3--]kinse (PI3K). Dr. Parks current research aims to investigate the role of bromodomain binding protein in ER stress, insulin resistance and obesity. Research Interests: The aim of my study is to understand the mechanism by which type2 diabetes and insulin resistance develop in obesity.
The major focus of my research is on the Molecular Genetics and Epidemiology in cancer and autoimmune disease. I have a broad background in human genetics with more than fifteen years of experience, including specific training and expertise in key research areas. I have identified 1) X-linked tumor suppressor gene FOXP3 and 2) genetic modifier CD24 in human autoimmune diseases. I have published more than 40 original research papers in peer-reviewed journals. Now I am leading independent research program with my collaborators to explore the molecular mechanisms of human diseases. His research interests are Cancer, Genetics, Epidemiology, Autoimmune diseases.
The major focus of my research is on the Molecular Genetics and Epidemiology in cancer and autoimmune disease. I have a broad background in human genetics with more than fifteen years of experience, including specific training and expertise in key research areas. I have identified 1) X-linked tumor suppressor gene FOXP3 and 2) genetic modifier CD24 in human autoimmune diseases. I have published more than 40 original research papers in peer-reviewed journals. Now I am leading independent research program with my collaborators to explore the molecular mechanisms of human diseases. His research interests are Cancer, Genetics, Epidemiology, Autoimmune diseases.
Dr. Guoli Zhou earned his Doctor of Medicine degree in Human Parasitology from Sun Yat-sen University of Medical Sciences in China and then received his MPH and PhD degrees in Epidemiology from Michigan State University. Dr. Zhou is an unconventional epidemiologist with a very strong research experience in biochemistry, molecular biology, and bioinformatics. At present, Dr. Zhou is a research assistant professor at Clinical and Translational Sciences Institute (CTSI) in Michigan State University. His current research focuses on exploring pathway-based biomarkers in maternal blood/urine, placenta, and fetal blood at the multiple omics levels (e.g., genetic polymorphisms, DNA methylation, miRNAs, mRNAs,
Dr. Guoli Zhou earned his Doctor of Medicine degree in Human Parasitology from Sun Yat-sen University of Medical Sciences in China and then received his MPH and PhD degrees in Epidemiology from Michigan State University. Dr. Zhou is an unconventional epidemiologist with a very strong research experience in biochemistry, molecular biology, and bioinformatics. At present, Dr. Zhou is a research assistant professor at Clinical and Translational Sciences Institute (CTSI) in Michigan State University. His current research focuses on exploring pathway-based biomarkers in maternal blood/urine, placenta, and fetal blood at the multiple omics levels (e.g., genetic polymorphisms, DNA methylation, miRNAs, mRNAs, proteomics, metabolomics, and microbiomics) in relation to spontaneous preterm birth/childhood sensorineural hearing loss/childhood autism in an epidemiologic context. Research interests are Molecular reproductive, perinatal, and pediatric epidemiology.
Dr. Yujiang Fang received his M.D. in 1993 and and Ph.D in 2000. Hehas worked as an attending urologist for years. Following postdoctoral training in pathology in Paris, France and postdoctoral training in immunology in Columbia, Missouri, he was a research assistant professor at the University of Missouri and adjunct assistant professor at several other universities. Dr. Fang is now an academic pathologist and assistant professor at Des Moinies University. A member of the editorial boards of several established journals, Dr. Fang has extensive involvement in clinical, teaching and research experiences. He is interested in cancer immunotherapy, the effect of
Dr. Yujiang Fang received his M.D. in 1993 and and Ph.D in 2000. Hehas worked as an attending urologist for years. Following postdoctoral training in pathology in Paris, France and postdoctoral training in immunology in Columbia, Missouri, he was a research assistant professor at the University of Missouri and adjunct assistant professor at several other universities. Dr. Fang is now an academic pathologist and assistant professor at Des Moinies University. A member of the editorial boards of several established journals, Dr. Fang has extensive involvement in clinical, teaching and research experiences. He is interested in cancer immunotherapy, the effect of radiosensitizers on cancer and the mechanisms of resolution and fibrosis of inflammation.
Dr. Zhao is a Clinical Assistant Professor at Tulane University School of Public Health and Tropical Medicine. Her research interests are focused on identifying and characterizing genetic variants that affecting susceptibility to complex human disorders, such as osteoporosis, obesity, and vitamin D deficiency. She has strong experience in molecular genetics, bioinformatics, genetic epidemiology, and bone biology. She has published more than 50 manuscripts in peer-reviewed journals. Abstracts of her work have been presented at twenty-nine conferences, along with plenary posters and oral presentations. Dr. Zhao is a reviewer for a multitude of scientific journals. She has received numerous awards, including
Dr. Zhao is a Clinical Assistant Professor at Tulane University School of Public Health and Tropical Medicine. Her research interests are focused on identifying and characterizing genetic variants that affecting susceptibility to complex human disorders, such as osteoporosis, obesity, and vitamin D deficiency. She has strong experience in molecular genetics, bioinformatics, genetic epidemiology, and bone biology. She has published more than 50 manuscripts in peer-reviewed journals. Abstracts of her work have been presented at twenty-nine conferences, along with plenary posters and oral presentations. Dr. Zhao is a reviewer for a multitude of scientific journals. She has received numerous awards, including the Alice L. Jee Memorial Young Investigator Award, ASBMR (American Society for Bone and Mineral Research) young investigator award, Young investigator award from International Chinese Hard Tissue Society (ICHTS), and various travel awards. My research interests are focused on identifying and characterizing genetic variants that affecting susceptibility to complex human disorders, such as osteoporosis, obesity, and vitamin D deficiency.
Ahmed Salem earned his bachelor degree in Pharmacy in 2004 and his PhD in 2010. He worked as a postdoctoral associate at Thomas Jefferson University and Yale University. Currently, he works as a research associate at University of California Riverside. He is studying tumor biology and targeting. His work elucidated the role of DNA damage and metabolic alterations in tumor microenvironment and tumor progression. He is performing RNA interference and small-molecule high-throughput screens to identify novel cancer targets. My research interest is to understand cancer biology and develop novel cancer therapies. Targeting those factors can modulate cancer aggressiveness and enhance
Ahmed Salem earned his bachelor degree in Pharmacy in 2004 and his PhD in 2010. He worked as a postdoctoral associate at Thomas Jefferson University and Yale University. Currently, he works as a research associate at University of California Riverside. He is studying tumor biology and targeting. His work elucidated the role of DNA damage and metabolic alterations in tumor microenvironment and tumor progression. He is performing RNA interference and small-molecule high-throughput screens to identify novel cancer targets. My research interest is to understand cancer biology and develop novel cancer therapies. Targeting those factors can modulate cancer aggressiveness and enhance cancer therapy. Currently, I am validating several novel DNA repair regulators resulted of the screen.
Dr. Yun Chen currently serves as the President & Principal Scientist of BrightstarTech, Inc., Maryland, USA. He received an MD in 1983 and an MS (Master of Surgery) in 1991 from Third Military Medical University, China. He received his Ph.D. in Pharmacology from the Hebrew University of Jerusalem, Israel in 1998. After completed his postdoctoral training in US National Institutes of Health, Dr. Chen worked for US Military Agencies such as USUHS, TAMC, USAMRICD, and MCS. Dr. Chen has proven expertise and experience in traumatic brain injury, spinal cord injury, ischemic stroke, organophosphate-induced brain damage, neuropsychiatric disorders, neuropharmacology, neurodegenerative diseases,
Dr. Yun Chen currently serves as the President & Principal Scientist of BrightstarTech, Inc., Maryland, USA. He received an MD in 1983 and an MS (Master of Surgery) in 1991 from Third Military Medical University, China. He received his Ph.D. in Pharmacology from the Hebrew University of Jerusalem, Israel in 1998. After completed his postdoctoral training in US National Institutes of Health, Dr. Chen worked for US Military Agencies such as USUHS, TAMC, USAMRICD, and MCS. Dr. Chen has proven expertise and experience in traumatic brain injury, spinal cord injury, ischemic stroke, organophosphate-induced brain damage, neuropsychiatric disorders, neuropharmacology, neurodegenerative diseases, gunshot wound, wound ballistics, blast injury, pathophysiology, and behavioral/cognitive evaluations. He has published a lot of papers in peer-reviewed journals and been granted five patents in USA and China, respectively. Dr. Chen is serving as an editorial board member, guest editor and peer reviewer of 17 biomedical journals published in USA, UK, Switzerland and Hong Kong. His research interests are Brain injury, Brain damage and subsequent neuropsychiatric disorders, Ischemic stroke,BBB damage and cerebrovascular insults, Neurodegenerative diseases, Neuroprotection and neurotherapies, Behavioral/cognitive evaluations, Gunshot injury/wound ballistics, Biomarker detection.
Dr. Archana Varma, MD PhD MDPHD practices medicine at Mankato, Minnesota and specializes in family medicine. Dr. Varma received her medical degree from University Of North Dakota School Of Medicine And Health Sciences. In addition to having active medical licenses, Dr. Varma has passed an automated background check which looked at elements including medical license status and malpractice screening (no history found).
Dr. Archana Varma, MD PhD MDPHD practices medicine at Mankato, Minnesota and specializes in family medicine. Dr. Varma received her medical degree from University Of North Dakota School Of Medicine And Health Sciences. In addition to having active medical licenses, Dr. Varma has passed an automated background check which looked at elements including medical license status and malpractice screening (no history found).
Dr. Alon Shamir has completed Ph.D. in psychobiology from Ben-Gurion University, Beer-Sheva, Israel followed by a research fellowship at NICHD, Bethesda, USA. He is the Head of the Psychobiology Research laboratory at Mazra Mental Health Center, Akko, Israel and a lecturer in the Ruth and Bruce Rappaport Faculty of Medicine Technion, Israel. He has published as first author and as part of a research team more than 20 peer-reviewed journal articles and several book chapters. Dr. Shamir laboratory focuses on using state of the art molecular methods and animal behavior paradigms to underlay the molecular mechanism of emotional processing
Dr. Alon Shamir has completed Ph.D. in psychobiology from Ben-Gurion University, Beer-Sheva, Israel followed by a research fellowship at NICHD, Bethesda, USA. He is the Head of the Psychobiology Research laboratory at Mazra Mental Health Center, Akko, Israel and a lecturer in the Ruth and Bruce Rappaport Faculty of Medicine Technion, Israel. He has published as first author and as part of a research team more than 20 peer-reviewed journal articles and several book chapters. Dr. Shamir laboratory focuses on using state of the art molecular methods and animal behavior paradigms to underlay the molecular mechanism of emotional processing and cognitive function in general and in schizophrenia, in particular. A major focus of Dr. Shamir is on the involvement of the ErbB signaling pathways in the processes of these complex behaviors. In additional to basic experimental capabilities, Dr Shamir laboratory is using several approaches to monitor emotional processing and cognitive functioning to identify polygenic and epigenetic susceptibility peripheral markers for prodromal diagnostic of schizophrenia and other psychiatry disorders. Dr. Shamir is working closely with the center clinical psychiatrists with a goal to improve the patient quality of life, and to pave the way for better diagnosis management and treatment.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97